CMBA
TMCI icon

C.M. Bidwell & Associates’s Treace Medical Concepts TMCI Stock Holding History

C.M. Bidwell & Associates’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$673 Buy
+169
New +$465 ﹤0.01% 467

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

C.M. Bidwell & Associates's TMCI Position: Q2 2026 in Review

C.M. Bidwell & Associates opened a new position in Treace Medical Concepts (TMCI) in Q2 2026: 169 shares worth $673. The stake represents ﹤0.01% of the portfolio and ranks #467 among its holdings.

117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • C.M. Bidwell & Associates held 169 shares of Treace Medical Concepts worth $673 as of Q2 2026.
  • Treace Medical Concepts was a new C.M. Bidwell & Associates position in Q2 2026.
  • Treace Medical Concepts made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #467 holding.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.